Public (NYSE: TXG)
Acquired by Pfizer
Acquired by AT&T
Public (NASDAQ: ATHN)
Public (NASDAQ: NET)
Acquired by MorphoSys
Acquired by Novo Nordisk
Acquired by Unilever
Public (NASDAQ: LCID)
Acquired by Google
Acquired by Empower Retirement
Acquired by Celgene
Public (NASDAQ: RGNX)
Public (NASDAQ: SWAV)
Public (NASDAQ: ZLTQ)
Acquired by Great Hill
Venrock consists of two separate investment programs: a traditional venture capital program, focused on early stage investing in healthcare and technology companies; and a later-stage healthcare program, which implements a venture capital-like long-term approach to investment opportunities in small capitalization public companies and late-stage private healthcare companies. Click here for the later-stage healthcare program website.
This website is intended solely to provide general information regarding Venrock and is not an offer or solicitation with respect to the purchase or sale of any security. The material contained on this website is intended for financially sophisticated investors. Venrock does not solicit or make its services generally available to the public. Further, the information contained on this site, including information regarding investments and Venrock’s portfolio company experience, may not be relied on in any manner as legal, tax, accounting or investment advice. Past performance is not indicative of future results and it should not be assumed that results for any investments or portfolio companies described herein will be achieved for other investments or portfolio companies. Portfolio company information and team member profiles are not considered to be a complete list. In particular, the portfolio companies described herein were selected based, in part, on their positive investment performance relative to other Venrock investments. The content provided on this site is provided to users “AS IS”, and Venrock does not make any representation or warranty, express or implied, as to the accuracy or completeness of the information contained on this site.